» Articles » PMID: 28877359

Food Elimination Diets Are Effective for Long-term Treatment of Adults with Eosinophilic Oesophagitis

Overview
Date 2017 Sep 7
PMID 28877359
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Limited data describe the long-term efficacy of dietary elimination in eosinophilic oesophagitis (EoE).

Aim: To assess the long-term outcomes of food elimination diets for treatment of adults with EoE.

Methods: We conducted a retrospective cohort study at our centre analysing all EoE patients receiving a food elimination diet without concomitant steroids. Baseline data were abstracted using standardised collection forms. Follow-up data from a mean 24.9-month period were collected for patients with a histological response to a food elimination diet during and after food reintroduction. The main outcomes were symptomatic, endoscopic and histological responses.

Results: Of 52 patients, 18 received a 6-food food elimination diet, 32 received targeted diet, and two received a 6-food food elimination diet with targeted elimination. There were 21 (40%) patients with an initial histological response. Responders reported less dysphagia after treatment (95% baseline vs 11%; P = .001) and at the end of follow-up (95% baseline vs 33%; P = .008). Significant and durable endoscopic improvements were recorded at the same time points: Endoscopic reference score: 3.2 vs 0.7; P = .001; and 3.2 vs 1.7; P = .06. Histological findings improved after the most restrictive diet in responders (49.8 vs 4.1 eosinophils per high-power field; P = .001) and remained suppressed in the 10 initial responders maintaining compliance at the end of follow-up (5.2 eosinophils per high-power field).

Conclusions: Among EoE patients responding to a food elimination diet and remaining adherent, maintenance dietary therapy produced durable long-term symptomatic, endoscopic and histological disease control. These long-term data confirm that a food elimination diet is an effective maintenance treatment option in select adults with EoE.

Citing Articles

Histologic Response or Endoscopic Normalization After Initial Treatment for Eosinophilic Esophagitis in Children Leads to Less Fibrostenosis over Long-Term Follow-Up.

Thel H, Borinsky S, LaFata S, Gee T, Cameron B, Xue A Dig Dis Sci. 2025; .

PMID: 39960589 DOI: 10.1007/s10620-025-08914-2.


Practice patterns for eosinophilic esophagitis vary widely among Canadian gastroenterologists: a nationwide survey.

Fetz A, Hemy A, Kim H, Moosavi S J Can Assoc Gastroenterol. 2025; 8(1):13-20.

PMID: 39906276 PMC: 11788507. DOI: 10.1093/jcag/gwae033.


Development and Validation of the PICK-UP-STRICS Score to Predict Fibrostenosis in Patients with EoE Prior to Endoscopy.

Chang J, LaFata S, Gee T, Redd W, Barlowe T, Cotton C Dig Dis Sci. 2024; 70(1):292-297.

PMID: 39641895 DOI: 10.1007/s10620-024-08777-z.


Eosinophilic gastrointestinal disorders: a narrative review on clinical perspectives and research gaps in the Asian context.

Chiou F, Ng L, Loh W Transl Gastroenterol Hepatol. 2024; 9:69.

PMID: 39503038 PMC: 11535809. DOI: 10.21037/tgh-24-34.


Esophageal Candidiasis Is Strongly Associated With Treatment Response to Topical Steroids in Eosinophilic Esophagitis and Could Be a Marker of Adherence.

Cameron B, Xue A, Kiran A, LaFata S, Ocampo A, McCallen J Gastro Hep Adv. 2024; 3(5):612-614.

PMID: 39165420 PMC: 11330905. DOI: 10.1016/j.gastha.2024.03.003.


References
1.
Doerfler B, Bryce P, Hirano I, Gonsalves N . Practical approach to implementing dietary therapy in adults with eosinophilic esophagitis: the Chicago experience. Dis Esophagus. 2014; 28(1):42-58. DOI: 10.1111/dote.12175. View

2.
Konikoff M, Noel R, Blanchard C, Kirby C, Jameson S, Buckmeier B . A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. Gastroenterology. 2006; 131(5):1381-91. DOI: 10.1053/j.gastro.2006.08.033. View

3.
Markowitz J, Spergel J, Ruchelli E, Liacouras C . Elemental diet is an effective treatment for eosinophilic esophagitis in children and adolescents. Am J Gastroenterol. 2003; 98(4):777-82. DOI: 10.1111/j.1572-0241.2003.07390.x. View

4.
Straumann A, Conus S, Degen L, Felder S, Kummer M, Engel H . Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis. Gastroenterology. 2010; 139(5):1526-37, 1537.e1. DOI: 10.1053/j.gastro.2010.07.048. View

5.
Liacouras C, Furuta G, Hirano I, Atkins D, Attwood S, Bonis P . Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol. 2011; 128(1):3-20.e6. DOI: 10.1016/j.jaci.2011.02.040. View